Literature DB >> 32428502

Caspase-8-Dependent Inflammatory Responses Are Controlled by Its Adaptor, FADD, and Necroptosis.

Bart Tummers1, Luigi Mari1, Clifford S Guy1, Bradlee L Heckmann1, Diego A Rodriguez1, Sebastian Rühl1, Julien Moretti2, Jeremy Chase Crawford1, Patrick Fitzgerald1, Thirumala-Devi Kanneganti1, Laura J Janke3, Stephane Pelletier1, J Magarian Blander4, Douglas R Green5.   

Abstract

Cell death pathways regulate various homeostatic processes. Autoimmune lymphoproliferative syndrome (ALPS) in humans and lymphoproliferative (LPR) disease in mice result from abrogated CD95-induced apoptosis. Because caspase-8 mediates CD95 signaling, we applied genetic approaches to dissect the roles of caspase-8 in cell death and inflammation. Here, we describe oligomerization-deficient Caspase-8F122GL123G/F122GL123G and non-cleavable Caspase-8D387A/D387A mutant mice with defective caspase-8-mediated apoptosis. Although neither mouse developed LPR disease, removal of the necroptosis effector Mlkl from Caspase-8D387A/D387A mice revealed an inflammatory role of caspase-8. Ablation of one allele of Fasl, Fadd, or Ripk1 prevented the pathology of Casp8D387A/D387AMlkl-/- animals. Removing both Fadd alleles from these mice resulted in early lethality prior to post-natal day 15 (P15), which was prevented by co-ablation of either Ripk1 or Caspase-1. Our results suggest an in vivo role of the inflammatory RIPK1-caspase-8-FADD (FADDosome) complex and reveal a FADD-independent inflammatory role of caspase-8 that involves activation of an inflammasome.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FADD; Inflammasome; apoptosis; autoimmune lymphoproliferative syndrome; caspase; inflammation; necroptosis; pyroptosis

Mesh:

Substances:

Year:  2020        PMID: 32428502      PMCID: PMC7306001          DOI: 10.1016/j.immuni.2020.04.010

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  63 in total

1.  The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism.

Authors:  James M Murphy; Peter E Czabotar; Joanne M Hildebrand; Isabelle S Lucet; Jian-Guo Zhang; Silvia Alvarez-Diaz; Rowena Lewis; Najoua Lalaoui; Donald Metcalf; Andrew I Webb; Samuel N Young; Leila N Varghese; Gillian M Tannahill; Esme C Hatchell; Ian J Majewski; Toru Okamoto; Renwick C J Dobson; Douglas J Hilton; Jeffrey J Babon; Nicos A Nicola; Andreas Strasser; John Silke; Warren S Alexander
Journal:  Immunity       Date:  2013-09-05       Impact factor: 31.745

2.  Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis.

Authors:  Kim Newton; Katherine E Wickliffe; Debra L Dugger; Allie Maltzman; Merone Roose-Girma; Monika Dohse; László Kőműves; Joshua D Webster; Vishva M Dixit
Journal:  Nature       Date:  2019-09-11       Impact factor: 49.962

3.  A functional role for Nlrp6 in intestinal inflammation and tumorigenesis.

Authors:  Grace Y Chen; Maochang Liu; Fuyuan Wang; John Bertin; Gabriel Núñez
Journal:  J Immunol       Date:  2011-05-04       Impact factor: 5.422

Review 4.  The many roles of FAS receptor signaling in the immune system.

Authors:  Andreas Strasser; Philipp J Jost; Shigekazu Nagata
Journal:  Immunity       Date:  2009-02-20       Impact factor: 31.745

5.  The Pseudokinase MLKL and the Kinase RIPK3 Have Distinct Roles in Autoimmune Disease Caused by Loss of Death-Receptor-Induced Apoptosis.

Authors:  Silvia Alvarez-Diaz; Christopher P Dillon; Najoua Lalaoui; Maria C Tanzer; Diego A Rodriguez; Ann Lin; Marion Lebois; Razq Hakem; Emma C Josefsson; Lorraine A O'Reilly; John Silke; Warren S Alexander; Douglas R Green; Andreas Strasser
Journal:  Immunity       Date:  2016-08-11       Impact factor: 31.745

6.  Structural and biochemical studies on procaspase-8: new insights on initiator caspase activation.

Authors:  Nadine Keller; Jirí Mares; Oliver Zerbe; Markus G Grütter
Journal:  Structure       Date:  2009-03-11       Impact factor: 5.006

7.  Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4.

Authors:  Kim Newton; Xiaoqing Sun; Vishva M Dixit
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

8.  AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC.

Authors:  V Sagulenko; S J Thygesen; D P Sester; A Idris; J A Cridland; P R Vajjhala; T L Roberts; K Schroder; J E Vince; J M Hill; J Silke; K J Stacey
Journal:  Cell Death Differ       Date:  2013-05-03       Impact factor: 15.828

9.  NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis.

Authors:  Eran Elinav; Till Strowig; Andrew L Kau; Jorge Henao-Mejia; Christoph A Thaiss; Carmen J Booth; David R Peaper; John Bertin; Stephanie C Eisenbarth; Jeffrey I Gordon; Richard A Flavell
Journal:  Cell       Date:  2011-05-12       Impact factor: 41.582

Review 10.  The role of necroptosis in cancer biology and therapy.

Authors:  Yitao Gong; Zhiyao Fan; Guopei Luo; Chao Yang; Qiuyi Huang; Kun Fan; He Cheng; Kaizhou Jin; Quanxing Ni; Xianjun Yu; Chen Liu
Journal:  Mol Cancer       Date:  2019-05-23       Impact factor: 27.401

View more
  25 in total

1.  Necrostatin-1 Relieves Learning and Memory Deficits in a Zebrafish Model of Alzheimer's Disease Induced by Aluminum.

Authors:  Xiaocheng Gao; Ping Zhang; Jianping Chen; Lan Zhang; Nan Shang; Jin Chen; Rong Fan; Yanhong Wang; Tao Huang; Qiao Niu; Qinli Zhang
Journal:  Neurotox Res       Date:  2022-01-04       Impact factor: 3.911

2.  Caspase-8 and FADD prevent spontaneous ZBP1 expression and necroptosis.

Authors:  Diego A Rodriguez; Giovanni Quarato; Swantje Liedmann; Bart Tummers; Ting Zhang; Cliff Guy; Jeremy Chase Crawford; Gustavo Palacios; Stephane Pelletier; Halime Kalkavan; Jeremy J P Shaw; Patrick Fitzgerald; Mark J Chen; Siddharth Balachandran; Douglas R Green
Journal:  Proc Natl Acad Sci U S A       Date:  2022-10-03       Impact factor: 12.779

3.  A causal variant rs3769823 in 2q33.1 involved in apoptosis pathway leading to a decreased risk of non-small cell lung cancer.

Authors:  Xu Zhang; Na Qin; Jingyi Fan; Chang Zhang; Qi Sun; Yayun Gu; Meng Zhu; Erbao Zhang; Juncheng Dai; Guangfu Jin; Hongxia Ma; Zhibin Hu; Hongbing Shen
Journal:  Cancer Biol Med       Date:  2022-09-02       Impact factor: 5.347

4.  Myeloid caspase-8 restricts RIPK3-dependent proinflammatory IL-1β production and CD4 T cell activation in autoimmune demyelination.

Authors:  Sunja Kim; Hsueh Chung Lu; Andrew J Steelman; Jianrong Li
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-07       Impact factor: 12.779

5.  Mechanisms in Graves Eye Disease: Apoptosis as the End Point of Insulin-Like Growth Factor 1 Receptor Inhibition.

Authors:  Syed A Morshed; Risheng Ma; Rauf Latif; Terry F Davies
Journal:  Thyroid       Date:  2022-04       Impact factor: 6.506

Review 6.  Cell death pathways: intricate connections and disease implications.

Authors:  Matthias Kist; Domagoj Vucic
Journal:  EMBO J       Date:  2021-01-13       Impact factor: 11.598

7.  Generation of Casp8 FL122/123GG Mice Using CRISPR-Cas9 Technology.

Authors:  Stephane Pelletier; Bart Tummers; Douglas R Green
Journal:  STAR Protoc       Date:  2020-11-25

Review 8.  The Role of the Key Effector of Necroptotic Cell Death, MLKL, in Mouse Models of Disease.

Authors:  Emma C Tovey Crutchfield; Sarah E Garnish; Joanne M Hildebrand
Journal:  Biomolecules       Date:  2021-05-28

9.  TNF Signaling Dictates Myeloid and Non-Myeloid Cell Crosstalk to Execute MCMV-Induced Extrinsic Apoptosis.

Authors:  Pratyusha Mandal; A Louise McCormick; Edward S Mocarski
Journal:  Viruses       Date:  2020-10-28       Impact factor: 5.048

10.  Necroptosis restricts influenza A virus as a stand-alone cell death mechanism.

Authors:  Maria Shubina; Bart Tummers; David F Boyd; Ting Zhang; Chaoran Yin; Avishekh Gautam; Xi-Zhi J Guo; Diego A Rodriguez; William J Kaiser; Peter Vogel; Douglas R Green; Paul G Thomas; Siddharth Balachandran
Journal:  J Exp Med       Date:  2020-11-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.